Incidentally:
The patient that we used bronchitrol on (with the drug being used under special access) was a middle aged quadriplegic with pneumonia who was unable to effectively clear their sputum (despite seemingly recovering from their infection). So a different class to the usual cystic fibrosis patients, but not that different a mechanism.
(To put it simply - they were drowning in their phlegm)
The use of bronchitrol was quite impressive - and we were all convinced that the drug was what made the difference between the patient recovering and dying. Obviously you would need to see such improvements repeated on a much larger double blind controlled trial - but that is what has been/ is being done.
I am prepared to wait to see the long term results of this stock - understanding that market sentiment is against any pharmaceutical stocks in their research / development stage. But to my mind, that allows a long term cheaper entry point (not without risk).
- Forums
- ASX - By Stock
- agm wrap
Incidentally:The patient that we used bronchitrol on (with the...
-
- There are more pages in this discussion • 28 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add SNT (ASX) to my watchlist
|
|||||
Last
3.8¢ |
Change
-0.002(5.00%) |
Mkt cap ! $45.37M |
Open | High | Low | Value | Volume |
4.1¢ | 4.1¢ | 3.5¢ | $92.49K | 2.439M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 15261 | 3.8¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
3.9¢ | 33701 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 15261 | 0.038 |
1 | 113863 | 0.035 |
2 | 425000 | 0.033 |
3 | 170000 | 0.031 |
5 | 319666 | 0.030 |
Price($) | Vol. | No. |
---|---|---|
0.040 | 500000 | 2 |
0.041 | 141890 | 1 |
0.045 | 45224 | 1 |
0.047 | 88965 | 2 |
0.049 | 25000 | 1 |
Last trade - 15.44pm 19/07/2024 (20 minute delay) ? |
Featured News
SNT (ASX) Chart |